In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{f12594439ee54d739ef4082425bbadca,

title = "In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy",

author = "Hyukjin Lee",

year = "2022",

doi = "10.1126/sciadv.abj6901",

language = "American English",

journal = "Science Advances",

issn = "2375-2548",

publisher = "American Association for the Advancement of Science",

}